LYCOS RETRIEVER 
Fibroids: Procedures
built 636 days ago
X-ray guidance is used to locate the arteries supplying the fibroids, and Dr. Spies' studies showed the radiation dose during the procedure was extremely low. Outcomes on uterine fibroid and embolization illustrated 90% success rates, initial evaluation of Embosphere, Microspheres and subsequent FDA approval of Embospheres for Fibroid embolization and studies on menopause illustrating that only women in their late forties and above who underwent embolization had any increased risk of being advanced into the menopausal/peri-menopausal symptoms. Of course many patients who are suffering from symptomatic fibroids at that age are not reluctant to go into menopause and would welcome this change if it occurred in order to stop the severe bleeding and pain/pressure symptoms.
Source:
It is no longer necessary to suffer from uterine fibroids. A new, non-invasive, FDA approved alternative to a hysterectomy is now available, making treatment of uterine fibroids easy and fast. Because MRgFUS is an outpatient procedure, patients typically return to work and normal activities the next day.
Source:
Today many women can choose a safe, effective and non-surgical treatment option for symptomatic fibroids. This treatment is a procedure called uterine fibroid embolization or UFE. The UFE procedure is performed by an interventional radiologist, it takes approximately one hour and requires an overnight stay in the hospital. Most patients recover from the procedure in approximately one week.
Source:
At least 25 percent of women suffer from uterine fibroids and as many as 77 percent of women may actually have the condition but be unaware of it, according to the U.S. National Institutes of Health. Although the tumors are benign, there are several uncomfortable and often very painful symptoms such as heavy bleeding, frequent urination, cramping and painful periods. Traditionally, treatment options have included some rather expensive hormonal treatments or even invasive surgical procedures like hysterectomies and myomectomies.
Source:
Myomectomy is a procedure that removes fibroids while leaving the uterus intact. Depending on the size and locations of the fibroids, this procedure can be done through abdominal incision, with laparoscopy or through hysteroscopic resection. It is still major surgery and requires lengthy recovery time. The major drawback of this method is that fibroids often return.
Source:
Magnetic Resonance guided Focused Ultrasound (MRgFUS) has been demonstrated as a viable option for effectively treating uterine fibroids. Compared to traditional hysterectomy, which is the primary treatment option for uterine fibroids, MRgFUS offers both clinical and economic advantages. Because it is a non-invasive procedure, patients avoid the risks associated with surgery, require only limited conscious sedation, and can return to normal activities the next day compared to lengthy recovery times and hospitalization days for the more traditional hysterectomy surgery. This translates into a significant economic impact for patients who undergo the MRgFUS procedure with documented fewer disability days (decreased days of missed work or days in bed) and lower use of medical resources: 83% fewer physician visits, 66% fewer additional diagnostic tests, and 66% fewer additional procedures.
Source:
MORE ABOUT
Procedures